We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.40 | 0.20% | 1,708.60 | 1,708.60 | 1,708.80 | 1,713.00 | 1,699.40 | 1,701.60 | 11,522,668 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.27 | 70.34B |
TIDMGSK
RNS Number : 1864N
GlaxoSmithKline PLC
15 January 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Ms E N Walmsley === ======================== =========================================== b) Position/status Chief Executive Officer === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 1535.597 ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Mr R G Connor === ======================== =========================================== b) Position/status President, Global Vaccines === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 42.320 ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Mr S P Dingemans === ========================= =========================================== b) Position/status Chief Financial Officer === ========================= =========================================== c) Initial notification/ Initial notification amendment === ========================= =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ========================= =========================================== b) LEI 5493000HZTVUYLO1D793 === ========================= =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ========================= =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ========================= =========================================== c) Price(s) and volume(s) Price(s) Volume(s) ---------- GBP15.2875 1050.550 ---------- === ========================= =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ========================= =========================================== e) Date of the 2019-01-11 transaction === ========================= =========================================== f) Place of the transaction London Stock Exchange (XLON) === ========================= =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Mr J Ford === ======================== =========================================== b) Position/status SVP & General Counsel === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 0.012 ---------- === ======================== ===========================================
d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ========================================================================= a) Name Mr J Ford === ======================== =============================================== b) Position/status SVP & General Counsel === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 10 January 2019. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- $39.4400 75.536 ---------- === ======================== =============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =============================================== e) Date of the transaction 2019-01-11 === ======================== =============================================== f) Place of the New York Stock Exchange (XNYS) transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Mr N Hirons === ======================== =========================================== b) Position/status SVP, Global Ethics & Compliance === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 309.578 ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ======================================================================= a) Name Mr N Hirons === ====================== =============================================== b) Position/status SVP, Global Ethics & Compliance === ====================== =============================================== c) Initial notification/ Initial notification amendment === ====================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================= a) Name GlaxoSmithKline plc === ====================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================= a) Description American Depositary Shares ('ADSs') of the financial ISIN: US37733W1053 instrument === ====================== =============================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 10 January 2019 === ====================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- $39.4400 18.799 ---------- === ====================== =============================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =============================================== e) Date of the 2019-01-11 transaction === ====================== =============================================== f) Place of the New York Stock Exchange (XNYS) transaction === ====================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') ======================================================================== a) Name Mr B McNamara === ======================= =============================================== b) Position/status CEO, GSK Consumer Healthcare === ======================= =============================================== c) Initial notification/ Initial notification amendment === ======================= =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================= =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================= =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description American Depositary Shares ('ADSs') of the financial ISIN: US37733W1053 instrument === ======================= =============================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 10 January 2019 === ======================= =============================================== c) Price(s) and Price(s) Volume(s)
volume(s) ---------- $39.4400 424.074 ---------- === ======================= =============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================= =============================================== e) Date of the 2019-01-11 transaction === ======================= =============================================== f) Place of the New York Stock Exchange (XNYS) transaction === ======================= =============================================== 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Mr D Redfern === ======================== =========================================== b) Position/status Chief Strategy Officer === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 1945.478 ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Mr R Simard === ======================== =========================================== b) Position/status President, Pharma Supply Chain === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 363.181 ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ===================================================================== a) Name Ms C Thomas === ======================== =========================================== b) Position/status SVP, Human Resources === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 357.061 ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2019-01-11 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') ============================================================================ a) Name Mr P C Thomson === ====================== ==================================================== b) Position/status President, Global Affairs === ====================== ==================================================== c) Initial notification/ Initial notification amendment === ====================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================================ a) Name GlaxoSmithKline plc === ====================== ==================================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================================ a) Description Ordinary shares of 25 pence each ('Ordinary of the financial Shares') instrument ISIN: GB0009252882 === ====================== ====================================================
b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ====================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 210.297 ---------- === ====================== ==================================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ==================================================== e) Date of the 2019-01-11 transaction === ====================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ============================================================================ a) Name Mrs K Thomson === ====================== ==================================================== b) Position/status PCA of Mr P C Thomson (President, Global Affairs) === ====================== ==================================================== c) Initial notification/ Initial notification amendment === ====================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================================ a) Name GlaxoSmithKline plc === ====================== ==================================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================================ a) Description Ordinary shares of 25 pence each ('Ordinary of the financial Shares') instrument ISIN: GB0009252882 === ====================== ==================================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 January 2019. === ====================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP15.2875 127.445 ---------- === ====================== ==================================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== ==================================================== e) Date of the 2019-01-11 transaction === ====================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHDELFFKFFFBBX
(END) Dow Jones Newswires
January 15, 2019 12:15 ET (17:15 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions